Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM.NS

539.15 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q2
Revenue 746.92614.39434.86472.34578.29601.53554.541601.398605.262605.969521.355544.739594.887599.986427.665571.043563.527316.521295.175420.104418.059452.34384.022418.945441.249424.04326.731380.565289.068268.965293.589343.824400.19402.417392.033346.107332.78369.885388.486324.286329.606339.131312.808377.016367.897380.788381.331493.212417.833372.269414.619465.967476.549
Cost of Revenue 263.61405.4317.87197.41209.09222.89234.033228.4209.376255.259242.937217.337235.082265.701152.055252.878278.944125.46378.68139.854158.87184.907139.557179.664196.571213.529112.691203.08155.124140.20686.893171.186168.772162.646142.861126.424128.497193.451228.171156.942148.112153.60967.344189.614178.484211.618214.702264.682207.829174.409191.384220.679228.948
Gross Profit 483.31208.99116.99274.93369.2378.64320.508372.998395.886350.71278.418327.402359.805334.285275.61318.165284.583191.058216.495280.25259.189267.433244.465239.281244.678210.511214.04177.485133.944128.759206.696172.638231.418239.771249.172219.683204.283176.434160.315167.344181.494185.522245.464187.402189.413169.17166.629228.53210.004197.86223.235245.288247.601
Gross Profit Ratio 0.6470.340.2690.5820.6380.6290.5780.620.6540.5790.5340.6010.6050.5570.6440.5570.5050.6040.7330.6670.620.5910.6370.5710.5550.4960.6550.4660.4630.4790.7040.5020.5780.5960.6360.6350.6140.4770.4130.5160.5510.5470.7850.4970.5150.4440.4370.4630.5030.5310.5380.5260.52
Reseach & Development Expenses 000000000000003.4580001.5410001.2090003.7430005.6440004.6880003.2850005.5480006.933000000
General & Administrative Expenses 000000-50.923000165.93500018.8000122.09000000000000000000000000.4520000.4000000
Selling & Marketing Expenses 000000154.65000102.1900096.222000162.940000000000000000000000038.54700038.262000000
SG&A 132.46117.3394.3398.03126.7179.04103.727104.868117.015148.815268.125151.319140.8297.674115.022153.32156.58118.198285.03146.164124.69131.451122.424127.404126.476106.242123.473104.214110.49795.866114.81196.787101.144111.611125.86992.17496.74682.3694.79574.4875.4689.5328.81891.35497.29887.489333.71398.2296.3730000
Other Expenses 343.8714.4424.8725.2122.7419.9728.1517.40911.2073.135-28.82619.5362.8498.218-13.7385.3484.1357.845203.6926.5084.4386.712-4.1742.786220.580.879225.199198.1450.001169.1031.187166.024216.418222.267209.136202.697186.24157.776150.427155.8150.001163.363214.62164.84177.271155.5862.912199.817189.968184.7763.214203.233204.538
Operating Expenses 343.87117.3394.33245.09290.1296.2270.995289.96268.899288.461273.723274.99259.273244.374219.144256.081238.987167.341203.692257.205236.783247.922211.838219.582220.58200.591225.199198.145171.477169.103204.567166.024216.418222.267209.136202.697186.24157.776150.427155.815163.769163.363214.62164.84177.271155.586154.995199.817189.968184.776195.708203.233204.538
Operating Income 139.4491.6622.6655.05101.8482.4477.634100.447138.19462.249-2.98552.412100.53289.91156.46662.08445.59623.71712.80323.04522.40619.51132.62719.69924.0989.92-11.159-22.926-39.44842.2070.974128.6836.2938.01723.5884.8645.9756.325-0.6810.3286.97110.09812.52811.740.9590.086-2.08915.547.4941.50612.69731.74632.701
Operating Income Ratio 0.1870.1490.0520.1170.1760.1370.140.1670.2280.103-0.0060.0960.1690.150.1320.1090.0810.0750.0430.0550.0540.0430.0850.0470.0550.023-0.034-0.06-0.1360.1570.0030.3740.0160.020.060.0140.0180.017-0.0020.0010.0210.030.040.0310.0030-0.0050.0320.0180.0040.0310.0680.069
Total Other Income Expenses Net 14.25-20.5622.7-2.26-2.2118.47-4.422-1.771-0.259-55.046-1.78418.9552.2157.16417.3653.9922.9676.5362.3955.4962.9575.5354.7431.744-1.974-0.829-0.528-2.266-1.914-1.863-1.155122.069-8.707-9.487-16.448-12.122-12.068-12.333-10.569-11.201-10.753-12.061-18.316-10.822-11.183-13.498-10.811-13.173-12.542-11.578-11.616-10.309-10.362
Income Before Tax 153.6971.145.3652.7999.63100.9173.21298.676137.9357.2032.00271.367102.74797.07573.83166.07648.56330.25315.19828.54125.36325.04637.3721.44322.1249.091-11.687-22.926-39.447-42.2070.974128.6836.2938.01723.5884.8645.9756.325-0.6810.3286.97210.09812.52811.740.9590.0860.82315.547.4941.50615.91131.74632.701
Income Before Tax Ratio 0.2060.1160.1040.1120.1720.1680.1320.1640.2280.0120.0040.1310.1730.1620.1730.1160.0860.0960.0510.0680.0610.0550.0970.0510.050.021-0.036-0.06-0.136-0.1570.0030.3740.0160.020.060.0140.0180.017-0.0020.0010.0210.030.040.0310.00300.0020.0320.0180.0040.0380.0680.069
Income Tax Expense 39.117.819.8713.1624.9125.917.18720.82733.8123.511.75217.30229.67328.59422.84211.7738.4755.05-0.355.7095.0725.0097.62444.4251.8180.608-0.456-0.9130-7.18429.6411.261.6033.5771.3731.591.67-1.360.0663.330.3082.8480.90.05-2.4644.73.31.56.5078.5237.3
Net Income 114.5953.2935.4939.6374.7274.7956.02277.85104.1233.6930.2554.06573.07468.48150.98954.30340.08825.20315.54822.83220.29120.03729.74617.44317.6997.273-12.295-22.47-38.534-42.2078.15899.0425.0336.41420.0113.4914.3854.6550.6790.2623.6727.09812.228.8920.0590.0363.28710.844.1940.0069.40323.22325.401
Net Income Ratio 0.1530.0870.0820.0840.1290.1240.1010.1290.1720.00600.0990.1230.1140.1190.0950.0710.080.0530.0540.0490.0440.0770.0420.040.017-0.038-0.059-0.133-0.1570.0280.2880.0130.0160.0510.010.0130.0130.0020.0010.0110.0210.0390.024000.0090.0220.0100.0230.050.053
EPS 4.292.011.311.512.852.852.142.973.970.140.012.022.512.611.942.071.530.960.590.870.770.761.140.670.680.28-0.47-0.86-1.47-1.610.313.780.190.240.760.130.170.180.0250.010.140.270.470.340.0020.0010.130.410.1600.360.890.97
EPS Diluted 4.251.931.311.472.852.852.142.973.970.140.012.022.512.611.942.071.530.960.590.870.770.761.140.670.680.28-0.47-0.86-1.47-1.610.313.780.190.240.760.130.170.180.0250.010.140.270.470.340.0020.0010.130.410.1600.360.890.97
EBITDA 179.39102.3826.6959.17106.39106.3482.422103.746140.22967.316-2.46875.649105.658100.96374.39370.17552.47834.30718.68932.14829.51629.08439.90224.79126.59713.339-11.008-20.449-37.343-37.6975.6049.94322.2824.54749.32824.40825.35125.57215.49118.70524.90629.26837.69529.95219.24420.49518.09735.81627.02819.60233.32749.60549.278
EBITDA Ratio 0.240.1670.0610.1250.1840.1770.1490.1730.2320.111-0.0050.1390.1780.1680.1740.1230.0930.1080.0630.0770.0710.0640.1040.0590.060.031-0.034-0.054-0.129-0.140.0190.0290.0560.0610.1260.0710.0760.0690.040.0580.0760.0860.1210.0790.0520.0540.0470.0730.0650.0530.080.1060.103